FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968658625> ?p ?o ?g. }

• W2968658625 abstract "Nephrotic range proteinuria and chronic renal failure are associated with both qualitative and quantitative changes in lipoproteins and increased cardiovascular risk. LDL exhibits heterogeneity with increased small dense LDL (LDLIII) associated with increased risk of coronary heart disease (CHD). In normal populations, production of small dense LDL is physiologically linked to mild hypertriglyceridaemia and low HDL, a combination that has been labelled 'the atherogenic lipoprotein phenotype'. This thesis aimed to explore abnormalities in the metabolism of triglyceride-rich lipoproteins in patients with chronic renal dysfunction, with particular reference to changes in LDL subfraction distribution and remnant lipoprotein particles. The main population investigated were patients with nephrotic range proteinuria secondary to primary glomerular disease, however this work was extended to examine changes in lipoproteins in patients with proteinuria secondary to diabetic nephropathy in type 2 diabetes, and also patients with end-stage renal failure. Our hypothesis was that in patients with proteinuria, hypertriglyceridaemia occurs as a result of impaired catabolism of VLDL. The consequence is the generation of small dense LDL (LDLIII) and remnant lipoproteins, both of which are pathogenic agents which may contribute to accelerated vascular disease and to the rate of progression of renal failure. Quantitative analysis of both LDLIII and remnant lipoproteins was performed in 27 patients with nephrotic range proteinuria and well preserved renal function. This revealed a marked increased in plasma LDLIII concentration, to levels that are noted to be atherogenic in normal populations. This increase primarily due to a shift in particle size towards smaller denser particles. Remnant lipoproteins (RLP) were V similarly increased in proteinuric patients. The excess of both of these atherogenic particles was independently related to the increase in plasma triglyceride prevalent in this population, an increase that previously been demonstrated to result in part, from delayed clearance of the VLDL1 subfraction of very-low density lipoprotein (VLDL). The 27 patients studied were found to have normal in vitro lipase activity, however marked abnormalities in the lipid and apolipoprotein content of the VLDLI particles was observed. Despite apparently normal plasma concentration of both apolipoprotein (apo) CII and apoCIII, the patients with proteinuria possessed VLDLI particles that were deficient in both of these apolipoproteins. This deficiency was accompanied by a relative deficiency in both plasma and VLDLI apoE. VLDLI particles were also found to be smaller than those in the control group with a higher surface ratio of free cholesterol: phospholipid. The presence of smaller, free cholesterol enriched, apolipoprotein deficient particles could easily account for the observed delay in clearance of VLDLI observed in this population. 12 patients with >1.5g/24hrs of urinary albumin, hypercholesterolaemia and plasma triglyceride >1.5mmol/l were studied in a randomised crossover trial comparing the effects of a statin (cerivastatin) and a fibrate (fenofibrate) on the concentration of LDLIII and remnant lipoproteins (RLP). Fenofibrate produced a significant reduction in both LDLIII and RLP. Cerivastatin reduced LDLIII but not RLP, moreover the reduction in LDLIII was greater on fenofibrate than following cerivastatin. The two treatments also differed in the manner in which plasma LDLIII was reduced, thus the reduction in LDLIII following fenofibrate correlated with plasma triglyceride reduction whilst the LDLIII reduction on cerivastatin was associated with LDL-C reduction. Therefore fenofibrate seemed to reduce LDLIII by removing the excess triglyceride essential for formation of small dense LDL, with cerivastatin reducing LDLIII by decreasing the total amount of LDL present. (Abstract shortened by ProQuest.)." @default.
• W2968658625 created "2019-08-22" @default.
• W2968658625 creator A5068285451 @default.
• W2968658625 date "1999-01-01" @default.
• W2968658625 modified "2023-09-24" @default.
• W2968658625 title "The atherogenic lipoprotein phenotype in renal disease" @default.
• W2968658625 cites W147879066 @default.
• W2968658625 cites W151785074 @default.
• W2968658625 cites W1550111394 @default.
• W2968658625 cites W1651383390 @default.
• W2968658625 cites W1775749144 @default.
• W2968658625 cites W1885316912 @default.
• W2968658625 cites W1960623258 @default.
• W2968658625 cites W1964195293 @default.
• W2968658625 cites W1964232038 @default.
• W2968658625 cites W1965721108 @default.
• W2968658625 cites W1969070167 @default.
• W2968658625 cites W1969927159 @default.
• W2968658625 cites W1970039102 @default.
• W2968658625 cites W1971834210 @default.
• W2968658625 cites W1972221405 @default.
• W2968658625 cites W1975125777 @default.
• W2968658625 cites W1976861453 @default.
• W2968658625 cites W1980636050 @default.
• W2968658625 cites W1983055162 @default.
• W2968658625 cites W1983330637 @default.
• W2968658625 cites W1984467078 @default.
• W2968658625 cites W1985105107 @default.
• W2968658625 cites W1985279156 @default.
• W2968658625 cites W1991325639 @default.
• W2968658625 cites W1994134413 @default.
• W2968658625 cites W1995797667 @default.
• W2968658625 cites W1996312360 @default.
• W2968658625 cites W1996358023 @default.
• W2968658625 cites W1996810831 @default.
• W2968658625 cites W1996987629 @default.
• W2968658625 cites W1997063355 @default.
• W2968658625 cites W1997958094 @default.
• W2968658625 cites W1998034199 @default.
• W2968658625 cites W2000258515 @default.
• W2968658625 cites W2002183464 @default.
• W2968658625 cites W2003956286 @default.
• W2968658625 cites W2004809516 @default.
• W2968658625 cites W2005238318 @default.
• W2968658625 cites W2007190763 @default.
• W2968658625 cites W2007542782 @default.
• W2968658625 cites W2007908725 @default.
• W2968658625 cites W2008203103 @default.
• W2968658625 cites W2008589296 @default.
• W2968658625 cites W2010140657 @default.
• W2968658625 cites W2014759828 @default.
• W2968658625 cites W2015416939 @default.
• W2968658625 cites W2015882577 @default.
• W2968658625 cites W2018402667 @default.
• W2968658625 cites W2019295985 @default.
• W2968658625 cites W2019485322 @default.
• W2968658625 cites W2023043880 @default.
• W2968658625 cites W2025589168 @default.
• W2968658625 cites W2027415701 @default.
• W2968658625 cites W2028467547 @default.
• W2968658625 cites W2030344916 @default.
• W2968658625 cites W2030836558 @default.
• W2968658625 cites W2031638760 @default.
• W2968658625 cites W2031843030 @default.
• W2968658625 cites W2032457360 @default.
• W2968658625 cites W2036112920 @default.
• W2968658625 cites W2039480744 @default.
• W2968658625 cites W2039496923 @default.
• W2968658625 cites W2039831544 @default.
• W2968658625 cites W2046197010 @default.
• W2968658625 cites W2047070188 @default.
• W2968658625 cites W2048737387 @default.
• W2968658625 cites W2049031546 @default.
• W2968658625 cites W2049943894 @default.
• W2968658625 cites W2050758709 @default.
• W2968658625 cites W2051050154 @default.
• W2968658625 cites W2052779555 @default.
• W2968658625 cites W2053365438 @default.
• W2968658625 cites W2053802334 @default.
• W2968658625 cites W2056342151 @default.
• W2968658625 cites W2058423564 @default.
• W2968658625 cites W2059537042 @default.
• W2968658625 cites W2060225783 @default.
• W2968658625 cites W2061325834 @default.
• W2968658625 cites W2062811495 @default.
• W2968658625 cites W2063501171 @default.
• W2968658625 cites W2064070911 @default.
• W2968658625 cites W2068872582 @default.
• W2968658625 cites W2069142708 @default.
• W2968658625 cites W2069750854 @default.
• W2968658625 cites W2069763849 @default.
• W2968658625 cites W2072015280 @default.
• W2968658625 cites W2073751205 @default.
• W2968658625 cites W2074074086 @default.
• W2968658625 cites W2074391521 @default.
• W2968658625 cites W2075809484 @default.
• W2968658625 cites W2077760013 @default.
• W2968658625 cites W2077762329 @default.
• W2968658625 cites W2079110191 @default.
• W2968658625 cites W2082255901 @default.

• next